{"name":"Criterium, Inc.","slug":"criterium-inc","ticker":"","exchange":"","domain":"criterium.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"AMG 510","genericName":"AMG 510","slug":"amg-510","indication":"Non-small cell lung cancer with KRAS G12C mutation","status":"phase_3"}]}],"pipeline":[{"name":"AMG 510","genericName":"AMG 510","slug":"amg-510","phase":"phase_3","mechanism":"AMG 510 is a small-molecule inhibitor that selectively targets KRAS G12C mutations, blocking oncogenic signaling in cancer cells.","indications":["Non-small cell lung cancer with KRAS G12C mutation","Colorectal cancer with KRAS G12C mutation","Pancreatic cancer with KRAS G12C mutation"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNLWZwbVhYcHo4OEoxOWxvWGR5Q3F3WllzclhsLTBUdmU4S2ZGR2dINVZYMHJPbTdlbkM0dVN0RnB5NWdFbFdfOWx5X1p4bW5CNWVqNUVYVjMxTHhESWhlQi15cGpJa01yYXg4UF9HS2tGVFl2Yk5CLTNsSWVDZjBtM1hqc1BVakttX3FJ?oc=5","date":"2026-02-10","type":"pipeline","source":"finance.yahoo.com","summary":"Criterium Energy Provides Tungkal PSC Update and Outlines 2026 Budget - finance.yahoo.com","headline":"Criterium Energy Provides Tungkal PSC Update and Outlines 2026 Budget","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOTGpZMzlZVWQ5c1ZVUG9WVnhlOEFfUlA4ZUtuMU1CdWpxcktDWEJtX3FrY0xEWWtBVFdBUC1ET05zNWZsSDc5a2lTdHFnTWltNGZkN2J1Mk42aWRVb2RUZnJmWU9tMS1VcFRuZGhFTF84ZW9USFdXeUJBdFdoOFRnZ3EydTh0b0ZHRWE5Vks0TDF2MVNBNzBsdWlSd2FMQmt3OEVSVGtzWFdQdnNqSXRDZzRFOGtLYmw2M2NGUmFzV3RCOG1KSHhDNk1QaEVUU0d3MF9OTWxzRGpDY0x0M2dSLVJoZmNQSlE?oc=5","date":"2025-09-12","type":"pipeline","source":"PR Newswire","summary":"EFGH Steps Onto the World Stage as Title Sponsor of Tour de France EFGH Singapore Criterium 2025 - PR Newswire","headline":"EFGH Steps Onto the World Stage as Title Sponsor of Tour de France EFGH Singapore Criterium 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNT2RFWmF4OHFSZExIYzYwN084blVEODVCVXdTT2s4bVoxYnEyU0owM3lSdUduVEplcWE3R2FINU5rNldpQmZmN3BLdWpxTHVJaVBZd054eUUyc3I1cGZYLVVlSF9Wek9vTHNXVlJNcTcxQ2hLMmdwVEkwRmFVZkJWWGstQXpmc0ZmOEFXQXBxMmhNNVc4RDRmY1JPSmhBWUJwMmxv?oc=5","date":"2024-10-18","type":"regulatory","source":"Grand View Research","summary":"Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size & Outlook, 2030 - Grand View Research","headline":"Middle East & Africa Biologics Regulatory Affairs Outsourcing Market Size & Outlook, 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPUkxKelFha3RsVkYzbGkyaGo5VzdJcFRTSFpVWDc5NE5vWUxHWjA4YnNHZk9qTy1oWmFJenBvUGhBWmVSQnJsMEZPcW1WMjlUemZFaXFWczRpVXA4U1hHb3V5dThKaGp4OFY1ZmRzMnhNYTlzd2hIYkF5YTdLWWlYbXNGczlRLU83NEE?oc=5","date":"2024-07-22","type":"regulatory","source":"Grand View Research","summary":"Canada Regulatory Affairs Market Size & Outlook, 2025-2030 - Grand View Research","headline":"Canada Regulatory Affairs Market Size & Outlook, 2025-2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxNaWd6Q3Fhc0lNdTRDdHhCOHZDQTFCSDh1aURyVDB0aDE3V1pBb3M4bXVISFlESTc5amlYLUFNeVpGVmFuVWNNY2N5bWRYTEpOQnhaNlN0enl1eGQxSWJqSk5rdC1OcF9lY255TDhKQ1F3SXpmZnZmd0gxOVVzcEVqQkNqOHRoT0ky?oc=5","date":"2024-07-18","type":"regulatory","source":"Grand View Research","summary":"India Regulatory Affairs Market Size & Outlook, 2025-2030 - Grand View Research","headline":"India Regulatory Affairs Market Size & Outlook, 2025-2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxNV0tlYUpzSk9ZNlBiUkltanNuWTBwVVVteXYzeXB0cXZpSmtqVTZWZUlIbVJUamNRa0t3N2VaODI2WEVVbXNBaU82cFphdUx0YW51UDhIRWg3Ni1ZTHo0bk1PSUN0Q2t5NnNzZlZOZzFmek5STXZXaHlfNnlUaHdBbzhNS0tIdk14aVpub1B0VzRSNEVnOHdycFpBT2FRUHd6eWxwby1mczFncS1t?oc=5","date":"2023-01-26","type":"pipeline","source":"newswire.com","summary":"Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications - newswire.com","headline":"Criterium, Inc. Announces Formation of New Oncology Research Consortium for Genito-Urinary Indications","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxPRUQzSG9FX3RCSUVTb25lTVVIcl9nZkIzZGZEczhCTzZRc0NYUTNVZzY1U0dsYUNNbnpBTlZyZEZhZ3pYdWtmTFR1eFF5MU8yRG5xa2xHRzRHSUdHSi16SGZiRzJRMV83aVZKaHQ2Z3o3MnNvTU1hb1p0S2hmdHczVHRmdTlDaHdv?oc=5","date":"2022-12-08","type":"regulatory","source":"BioSpace","summary":"Regulatory Affairs Market Size To Hold USD 31 Bn By 2030 - BioSpace","headline":"Regulatory Affairs Market Size To Hold USD 31 Bn By 2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWEFVX3lxTFBhSEFfRFMwYkI4N2U1WGJhdTRtb2Z3cW9XbGVoSVV4S2xpWnlYaElLSVdHbTdOajA4QkZGSkRHdjd5NFdtczNERGl6ckJBVHdtRFEycVFZRk4?oc=5","date":"2008-01-02","type":"pipeline","source":"Pharma Voice","summary":"Marketplace - Pharma Voice","headline":"Marketplace","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":5,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}